Welcome to our dedicated page for CCC news (Ticker: CCC), a resource for investors and traders seeking the latest updates and insights on CCC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CCC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CCC's position in the market.
Clarivate Plc (NYSE: CCC) announced the integration of Darts-ip case law data with the Innography IP analytics solution, enhancing strategic decision-making in intellectual property management. This follows the acquisition of CPA Global, which expanded the firm's capabilities, offering multi-jurisdictional litigation data from 141 countries and insights from over 1.8 million patent cases. The integration aims to support patent research, competitive intelligence, and litigation strategies, ultimately helping clients lower costs and make informed decisions across the IP lifecycle.
Clarivate Plc (NYSE: CCC) has completed its acquisition of CPA Global, creating a significant intellectual property (IP) entity. This merger aims to enhance IP-related products and services for a global customer base. Jerre Stead, Executive Chairman of Clarivate, emphasized the advantages of combined resources to identify opportunities and reduce risks in innovation. Former CPA Global CEO Simon Webster expressed confidence in forming a global IP leader. The acquisition involved approximately 217 million shares, granting CPA Global shareholders 35% ownership in Clarivate.
Clarivate secured $1.6 billion in financing to address CPA Global’s $2 billion debt.
Clarivate Plc (NYSE: CCC) will release its third-quarter 2020 financial results on October 29, before the market opens. The earnings release and supplementary financial information will be available on the investor website. A conference call and webcast to discuss the results will occur at 8:00 AM Eastern Time on the same day. Interested parties can access the live audio by dialing designated numbers for the U.S., Canada, and international callers. An audio replay will be available for two weeks following the call.
Clarivate Plc has partnered with the Open Access Monitor in Germany to provide Web of Science data, promoting open access research in the DACH region (Germany, Austria, Switzerland). This initiative, supported by the German Federal Ministry of Education and Research, will enhance data collection on publication financing and trends. Clarivate aims to bolster its commitment to open research and community-driven projects, having previously integrated open access data into its citation indexes, now exceeding 12 million articles. This collaboration aims to facilitate better informed, data-driven decisions in the research community.
Clarivate Plc (NYSE:CCC) released the 2020 Pharmaceutical R&D Factbook, highlighting a decrease in global R&D spending to $80 billion in 2022, down from a predicted $86 billion. This marks the first decline since 2016, influenced by COVID-19 and its impact on drug development. Notably, the average drug development time decreased from 14.5 years in 2010 to 10.2 years in 2019. However, new molecular entity (NME) launches have dropped 22% since 2018, with the U.S. seeing a 25% decrease in launches, while China and Japan increased their NME launches by 11% since 2017.
Clarivate Plc (NYSE: CCC) has announced the naming of 24 new Citation Laureates, highlighting researchers whose work is considered 'Nobel class'. This year's honorees come from countries including the USA, Canada, Germany, Japan, South Korea, and the UK. Since 2002, Clarivate has recognized researchers based on citation data from the Web of Science, with only 5,700 papers cited over 2,000 times. To date, 54 Citation Laureates have received a Nobel Prize. Notable mention includes advances in personalized medicine, gender pay gap studies, and galaxy formation.
Clarivate Plc (NYSE: CCC) has released a report detailing indigenous research trends in Australia, New Zealand, and the Pacific Region. It highlights that only over 1% of regional research is indigenous-focused, with a significantly lower citation impact (CNCI of 0.65) compared to global baselines. The report shows New Zealand leads in research volume but not in impact per state. Major contributors include the Universities of Auckland, Sydney, and Otago, with Health, Society, and Culture being the prominent research areas under new FoR classifications. The full report is available for download.
